North Carolina Woman's Walk to the Store Becomes a Nightmare...And Now She's Fighting...
Incredible New Video Appears to Support Theory That Russians Shot Down Azerbaijan Airliner
Immigration Moratorium Now
Young Americans Shouldn’t Memory-Hole Soviet Horrors
Biden the Invisible President Lies Without Consequence
Time for Trump to Drop Lawsuits and for the Press to Apologize
Christmas Thanks for God’s Blessings
Biden Administration Nixes Plan to Expand Birth Control Access
Biden Commuted the Sentences of 37 Death Row Inmates. Here's How Trump Responded.
'Love Is Not Pedophilia': Judge Tears Into Gay Activists Convicted of Unconscionable Child...
NERC’s Grid Assessment Should Be a Wake-Up Call
Da Bears and the Donald
The Case of Daniel Penny: Lessons on Self-Defense
Celebrating the Miracle of Protection
The German Christmas Market Attack Demonstrates Perils of Mass Migration Policies
Tipsheet

'Brutal Day For The NYT': Paper Fact Checked Over Claim About Why Trump Is Pushing HCQ

AP Photo/Bebeto Matthews, File

The New York Times sank to a new low, even for them, publishing a story questioning whether President Trump was promoting hydroxychloroquine as a coronavirus treatment because it benefited him financially. 

Advertisement

The paper highlighted the president’s incredibly small financial stake in the maker of chloroquine.

If hydroxychloroquine becomes an accepted treatment, several pharmaceutical companies stand to profit, including shareholders and senior executives with connections to the president. Mr. Trump himself has a small personal financial interest in Sanofi, the French drugmaker that makes Plaquenil, the brand-name version of hydroxychloroquine. (NYT)

As he said on Tuesday, President Trump is a cheerleader for America. He wants this country to thrive. He wants its citizens to prosper. And he wants this virus to affect as few Americans as possible, which is why he has pushed HCQ so heavily—because thousands of doctors in the U.S. and around the world attest to the fact that it works. We don’t have time to waste in clinical trials right now. The suggestion that he’s pushing it for financial benefit is patently absurd. Fact checkers agreed.  

What's True

U.S. President Donald Trump earns some income from three family trusts that are administered independently by J.P. Morgan, an investment bank and wealth-management firm. These trusts are in part invested in mutual funds that themselves are partially invested in companies that produce hydroxychloroquine.

What's False

Trump’s financial stake in these companies is virtually negligible — contained indirectly via mutual funds — and administered through three family trusts he does not control. As a generic drug, hydroxychloroquine is unlikely to provide any one company with significant profits compared to other proprietary drugs. (Snopes)

Advertisement

Editor's Note: Want to support Townhall so we can keep telling the truth about China and the virus they unleashed on the world? Join Townhall VIP  and use the promo code WUHAN to get 25% off VIP membership!

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement